It should be noted that no account of the change in conforma-
tional entropy has been made here, and no absolute equilibrium
positions have been calculated. The calculations, however, imply
that far less of the phosphine borane enolate will be trapped in an
unreactive chelate than the equivalent phosphine oxide, and this is
why the enolate alkylation occurs in the former case. In addition,
warming of the enolates may increase the proportion of less stable
chelates. For the phosphine oxide, the next most stable structure
lacks chelation of the auxiliary, and this may explain why the
enolate decomposes with loss of, and subsequent alkylation of, the
oxazolidinone. For the phosphine borane enolates, however, loss
of chelation to the auxiliary carbonyl is energetically unfavourable,
which is consistent with the increased observed stability, and
stereocontrolled alkylation, of the borane enolate.
In brief, we have demonstrated that b-substituted phosphine
oxides undergo the phosphine oxide mediated cyclopropanation
cascade reaction to produce trans-disubstituted cyclopropyl ke-
tones in good yield. Moreover, we have extended the method to
the enantioselective synthesis of cyclopropyl ketones by employing
Evans’ oxazolidinone auxiliary and masking the phosphine oxide
as a phosphine borane.
29.0 (d, J 36, PCH2) and 20.9 (d, J 11.5, Me); dP (162 MHz; CDCl3)
15.6–15.3 (m); m/z (ESI) 468 (65%, MNa+), 454 (51, MNa - BH3),
446 (33, MH) and 369 (100, MH - Ph) (Found: MNa+, 468.19000.
C26H29NO3PBNa requires M, 468.18758).
(R)-Diphenyl(3-hydroxy-2-methylpropyl)phosphine borane 48
By the method of Roques et al.,23 to a suspension of sodium
borohydride (27 mg, 0.72 mmol) and lithium chloride (31 mg,
0.72 mmol) in ethanol : THF (2.9 cm3 : 2.9 cm3), stirred at
0
◦C under nitrogen, was added a solution of (4S,2¢R)-3-[3¢-
(boronatodiphenylphosphinyl)-2-methylpropionyl)]-4-(phenylme-
thyl)oxazolidin-2-one 45 (80 mg, 0.18 mmol) in ethanol : THF
(0.72 cm3 : 0.72 cm3). The resulting mixture was stirred for 18 h,
allowing to warm to room temperature slowly. The mixture was
treated with acetone (1 cm3) and the solvents removed in vacuo.
The residue was partitioned between EtOAc (2 ¥ 25 cm3) and
water (15 cm3) and the combined organic layers dried (Na2SO4),
filtered and the solvents removed in vacuo to give an oil. The oil
was purified by flash column chromatography (SiO2, EtOAc–
hexane 1 : 1, v/v) to give alcohol 48 (50 mg, 99%) as an oil; Rf
0.3 (EtOAc–hexane, 1 : 1, v/v); [a]2D3 (c = 0.5, CHCl3) -4.7; IR
nmax (film)/cm-1 3372 (br, O–H), 2925 (C–H), 2381 (B–H), 1589
Experimental procedures
=
(C C, Ph) and 1436 (P–Ph); dH (500 MHz; CDCl3) 7.73–7.68
(4H, m, Ph), 7.49–7.40 (6H, m, Ph), 3.51 (1H, ddd, J 11, 5 and
1.5, CHAHBO), 3.40 (1H, dd, J 11 and 6, CHAHBO), 2.58–2.50
(1H, m, PCHAHB), 2.09–2.02 (2H, m, CH and PCHAHB), 1.53
(1H, br s, OH), 1.32–0.70 (3H, m, BH3) and 0.93 (3H, d, J 6.5,
Me); dC (125 MHz; CDCl3) 132.2 (d, J 9, PPh2 ortho), 132.0 (d, J
9, PPh2 ortho), 131.2 (d, J 2.5, PPh2 para), 131.1 (d, J 2.5, PPh2
para), 130.1 (d, J 55.5, PPh2 ipso), 130.0 (d, J 54.5, PPh2 ipso),
128.8 (d, J 10, PPh2 meta), 67.8 (d, J 9.0, CH2O), 31.8 (CH), 28.8
(d, J 36, PCH2) and 18.6 (d, J 5.5, Me); dP (162 MHz; CDCl3)
14.9–14.4 (m); m/z (ESI) 295 (58%, MNa+) and 281 (100, MNa -
BH3) (Found: MNa+, 295.14000. C16H22OPBNa requires M,
295.13990).
A representative sequence of reactions for the conversion of
compound 44 into compound 54 is given below:
(4S,2¢R)-3-[3¢-(Boronatodiphenylphosphinyl)-2¢-methylpropionyl]-
4-(phenylmethyl)oxazolidin-2-one 45
To a solution of hexamethyldisilazane (0.23 cm3, 1.1 mmol) in
dry THF (6 cm3), stirred at -78 ◦C under argon, was added
n-butyllithium (1.5 M solution in hexanes, 0.68 cm3, 1.05 mmol).
After 20 min, a solution of (S)-3-[3¢-(boronatodiphenylphos-
phinyl)propionyl]-4-(phenylmethyl)oxazolidin-2-one 44 (0.43 g,
1.0 mmol) in dry THF (6 cm3), at -78 ◦C under argon, was
added via cannula. After 1 h, methyl iodide (0.12 cm3, 2.0 mmol)
was added and the reaction mixture allowed to warm to room
temperature. After 42 h, the solvent was removed in vacuo and
the residue partitioned between dichloromethane (50 cm3) and
water (25 cm3). The organic layer was dried (Na2SO4), filtered
and the solvent removed in vacuo. The residue was purified by
flash column chromatography (SiO2, EtOAc–hexane 1 : 3, v/v)
to give oxazolidinone 45 (0.34 g, 76%) as an oil; [a]2D3 (c = 0.5,
CHCl3) +58.3; IR nmax (film)/cm-1 2926 (C–H), 2380 (B–H), 1776
(R)-[3-(Benzoyloxy)-2-methylpropyl]diphenylphosphine oxide 51
By the method of Pellon et al.,20 a solution of (R)-diphenyl(3-
hydroxy-2-methylpropyl)phosphine borane 48 (0.14 g, 0.50 mmol)
in toluene (1.5 cm3) was treated with DABCO (56 mg, 0.50 mmol)
◦
and the resulting mixture heated at 40 C for 18 h. The mixture
was treated with excess hydrogen peroxide solution and the residue
quenched with sodium metabisulfite. The mixture was partitioned
between dichloromethane (15 cm3) and water (15 cm3), the organic
layer dried (Na2SO4), filtered and the solvent removed in vacuo
to give crude (R)-diphenyl(3-hydroxy-2-methylpropyl)phosphine
oxide. dH (400 MHz; CDCl3) 7.79–7.69 (4H, m, Ph ortho), 7.56–
7.42 (6H, m, Ph), 3.61 (1H, dd, J 11 and 4, CHAHBO), 3.45 (1H, dd,
J 11.5 and 7.5, CHAHBO), 2.36 (1H, dd, J 14 and 8.5, PCHAHB),
2.32 (1H, dd, J 8.5 and 4, PCHAHB), 2.14–2.04 (1H, m, PCH2CH)
and 0.98 (3H, dd, J 7 and 1.5, Me); dC (125 MHz; CDCl3) 133.1
(d, J 99.5, Ph ipso), 131.9 (d, J 2.5, Ph para), 131.8 (d, J 98, Ph
ipso), 130.9 (d, J 9, Ph ortho), 130.6 (d, J 9.5, Ph ortho), 128.8 (d,
J 11.5, Ph meta), 128.7 (d, J 11.5, Ph meta), 68.3 (d, J 4.5, CH2O),
35.7 (d, J 69.5, PCH2), 32.1 (d, J 4, PCH2CH) and 19.9 (d, J
13, Me); dP (162 MHz; CDCl3) 35.4; m/z (ESI) 275 (55%, MH+)
(Found: MH+, 275.1190. C16H20O2P requires M, 275.1201). The
=
=
and 1694 (C O), 1605 (C C, Ph) and 1437 (P–Ph); dH (500 MHz;
CDCl3) 7.74–7.70 (2H, m, PPh2 ortho), 7.67–7.63 (2H, m, PPh2
ortho), 7.51–7.38 (6H, m, PPh2), 7.31–7.28 (2H, m, Ph), 7.26–7.23
(1H, m, Ph para), 7.15–7.13 (2H, m, Ph), 4.37 (1H, ddt, J 9.5, 7
and 3.5, CHN), 4.15–4.03 (3H, m, CH2O and CHMe), 3.17–3.10
(2H, m, CHAHBPh and PCHAHB), 2.74 (1H, dd, J 13.5 and 9.5,
PhCHAHB), 2.26 (1H, ddd, J 14.5, 12 and 2.5, PCHAHB), 1.30 (3H,
dd, J 7 and 1, Me) and 1.12–0.64 (3H, m, BH3); dC (125 MHz;
CDCl3) 175.2 (d, J 2.5, CONCO2), 152.7 (CONCO2), 135.1 (Ph
ipso), 132.5 (d, J 9, PPh2 ortho), 132.5 (d, J 9.5, PPh2 ortho), 131.4
(d, J 2.5, PPh2 para), 131.1 (d, J 2.5, PPh2 para), 129.4 (Ph), 129.3
(d, J 55.0, PPh2 ipso), 128.9 (d, J 10, PPh2 meta), 128.9 (Ph), 128.9
(d, J 55, PPh2 ipso), 128.6 (d, J 10, PPh2 meta), 127.3 (Ph para),
66.2 (CH2O), 55.3 (CHN), 37.8 (PhCH2), 33.3 (d, J 2, CHMe),
This journal is
The Royal Society of Chemistry 2009
Org. Biomol. Chem., 2009, 7, 1323–1328 | 1327
©